Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 9, 2002
Site variability in treatment outcome in antidepressant trialsJay D Amsterdam, David J BrunswickBipolar Disorders|November 26, 2003
Antidepressant monotherapy for bipolar type II major depressionJay D Amsterdam, David J BrunswickProgress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2002
A single-site, double-blind, placebo-controlled, dose-ranging study of YKP10A--a putative, new antidepressantJay D Amsterdam, David J Brunswick, Miriam HundertJournal of Psychiatric Research|March 9, 2004
Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trialJay D Amsterdam, David J Brunswick, Michael GibertiniBipolar Disorders|March 6, 2004
Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rateJay D Amsterdam, Justine Shults, David J Brunswick, et al.Journal of Affective Disorders|October 19, 2004
PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depressionMartin Reivich, Jay D Amsterdam, David J Brunswick, et al.The American Journal of Psychiatry|September 30, 2003
Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imagingDavid J Brunswick, Jay D Amsterdam, P David Mozley, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 20, 2004
Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjectsDavid J Brunswick, David B P Goodman, John P O'Reardon, et al.Journal of Affective Disorders|June 14, 2002
Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatmentDavid J Brunswick, Jay D Amsterdam, Jan Fawcett, et al.Pageof 1